Hydroquinone inhibits PMA-induced activation of NFκB in primary human CD19+ B lymphocytes

Cell Biology and Toxicology

Volumn 16, Issue 1, 2000, Pages 41-57

  Pyatt, D W ^a   Yang, Y ^a   Stillman, W S ^a   Cano, L L ^a   Irons, Richard D ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

CD19+ B cells; Hydroquinone; NF B

Indexed keywords

CD19 ANTIGEN; HYDROQUINONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; DNA BINDING; DOSE RESPONSE; ELECTROPHORETIC MOBILITY; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOTOXICITY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034125757     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007644620655     Document Type: Article

References (40)

1. Aoyama K. Effects of benzene inhalation on lymphocyte subpopulations and immune response in mice. Toxicol Appl Pharmacol. 1986;85:92-101.
2. Baeuerle PA, Henkel T. Function and activation of NFKB in the immune system. Annu Rev Immunol. 1994;12:141-79.
3. Brennan P, O'Neill LAJ. 2-Mercaptoethanol restores the ability of nuclear factor kappaB (NFkappaB) to bind DNA in nuclear extracts from interleukin 1-treated cells incubated with pyrrolidine dithiocarbamate (PDTC) - evidence for oxidation of glutathione in the mechanism of inhibition of NFkappaB by PDTC. Biochem J. 1996;320:975-81.
4. Cheung SC, Nerland DE, Sonnenfeld G. Inhibition of interferon gamma production by benzene and benzene metabolites. J Natl Cancer Inst. 1988;80:1069-72.
5. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11: 1475-89.
6. Eastmond DA, Smith MT, Irons RD. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol Appl Pharmacol. 1987;91: 85-95.
7. Hiscott J, Marois J, Garoufalis J, D'Addario M. Characterization of a functional NF-kB site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol. 1993;13:6231-40.
8. Hsu HC, Tsai WH, Chen LY et al. Production of hematopoietic regulatory cytokines by peripheral blood mononuclear cells in patients with aplastic anemia. Exp Hematol. 1996;24:31-6.
9. Irons RD. Quinones as toxic metabolites of benzene. J Toxicol Environ Health. 1985;16:673-8.
10. Irons RD, Moore BJ. Effect of short term benzene administration on circulating lymphocyte subpopulations in the rabbit: evidence of a selective b-lymphocyte sensitivity. Res Commun Chem Pathol Pharmacol. 1980;27(1):147-55.
11. King AG, Landreth KS and Wierda D. Hydroquinone inhibits bone marrow pre-B cell maturation in vitro. Mol Pharmacol. 1987;32:807-12.
12. King AG, Landreth KS, Wierda D. Bone marrow stromal cell regulation of b-lymphopoiesis. II. Mechanisms of hydroquinone inhibition of pre-b cell maturation. J Pharmacol Exp Ther. 1989;250(2):582-90
13. Liou H-C, Sha WC, Scott ML, Baltimore D. Sequential induction of NJ-kB/Rel family proteins during B-cell terminal differentiation. Mol Cell Biol. 1994;14:5349-59.
14. Matthews JR, Hay RT. Regulation of the DNA binding activity of NF-kB. Int J Biochem Cell Biol. 1995;27:865-79.
15. 2 and antioxidants have opposite effects on activation of NF-kB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 1993;12:2005-15.
16. Pfeifer RW, Irons RD. Effect of benzene metabolites on phytohemagglutinin-stimulated lymphopoiesis in rat bone marrow. J Reticuloendoth Soc. 1982a;31:155-70.
17. Pfeifer RW, Irons RD. Quinones and sulfhydryl-dependent immunotoxicity. In: Proceedings of the thirteenth conference on environmental toxicology. Wright-Patterson Air Force Base: AFAMRL; 1982b:106-23.
18. Phillips RJ, Gustafson S, Ghosh S. Identification of a novel NF-kB p50-related protein in B lymphocytes. Mol Cell Biol. 1996;16:7089-97.
19. Pimentel-Muiños FX, Mazana J, Fresno M. Regulation of interleukin-2 receptor a chain expression and nuclear factor-kB activation by protein kinase C in T lymphocytes. J Biol Chem. 1994;269:24424-9.
20. Post GB, Snyder R, Kalf GF. Inhibition of RNA synthesis and interleukin-2 production on lymphocytes in vitro by benzene and its metabolites, hydroquinone and p-benzoquinone. Toxicol Lett. 1985;29:161-7.
21. + T lymphocytes. Toxicol Appl Pharmacol. 1998;149: 178-84.
22. Reya T, Grosschedl R. Transcriptional regulation of B-cell differentiation. Curr Opin Immunol. 1998;10:158-65.
23. Rozen MG, Snyder CA, Albert RE. Depressions in B- and T-lymphocyte mitogen-induced blastogenesis in mice exposed to low concentrations of benzene. Toxicol Lett. 1984;20: 343-9.
24. Schreck R, Baeuerle PA. Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NFKB. Methods Enzymol. 1994;234:151-63.
25. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J. 1999;10:2247-58.
26. Schreck R, Grassmann R, Fleckenstein B, Baeuerle PA. Anti-oxidants selectively suppress activation of NF-kB by human T-cell leukemia virus type 1 tax protein. J Virol. 1992a;66: 6288-93.
27. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor kB activation in intact cells. J Exp Med. 1992b;175:1181-94.
28. Schulze-Osthoff K, Los M, Baeuerle PA. Redox signaling by transcription factors NF-kappaB and AP-1 in lymphocytes. Biochem Pharmacol. 1995;50:735-41.
29. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986;46:705-16.
30. Sha WC, Liou H-C, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-kappaB leads to multi-focal defects in immune responses. Cell. 1995;80:321-30.
31. Snyder RS, Kocsis JJ. Current concepts of chronic benzene toxicity. Crit Rev Toxicol. 1975;June:265-88.
32. Snyder RS, Longacre SL, Sammett D, Witmer CM, Kocsis JJ. Relationship between the toxicity and metabolism of benzene. In: Mehlman MA, ed. Advances in modern environmental toxicology. Vol. 4. Carcinogenicity and toxicity of benzene. Princeton: Princeton Scientific Publishers, 1983:23-36.
33. Snyder R, Witz G, Goldstein BD. The toxicology of benzene. Environ Health Perspect. 1993;100:293-306.
34. Takahiro S, Takahashi T, Azuma T, Obata Y. Re1A deficient lymphocytes: normal development of T and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J Exp Med. 1998;185:953-61.
35. Weimels J, Smith MT. Enhancement of myeloid cell growth by benzene metabolites via the production of active oxygen species. Free Radic Res. 1999;30:93-103.
36. Wierda D, Irons RD. Hydroquinone and catechol reduce the frequency of progenitor B lymphocytes in mouse spleen and bone marrow. Immunopharmacology. 1982;4:41-54.
37. Wu M, Lee H, Bellas RE et al. Inhibition of NF-kB/rel induces apoptosis of murine B cells. EMBO J. 1996;15:4682-90.
38. Yin S-N, Li G-L, Tain F-D et al. A retrospective cohort study of leukemia and other cancers in benzene workers. Environ Health Perspect. 1989;82:207-13.
39. Young HA. Regulation of interferon-gamma gene expression. J Interferon Cytokine Res. 1996;16:563-8.
40. Ziegler-Heitbrock HWL, Sternsdorf T, Liese J et al. Pyrrolidine dithiocarbamate inhibits NF-kB mobilization and TNF production in human monocytes. J Immunol. 1993;151: 6986-93.